Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7942138

Spotlight On: Key questions emerging from ESC 2026

1+ week, 3+ day ago   (10+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7895753

Network Bio launches with $50M to read the???barcodes??? of disease

3+ week, 3+ day ago   (13+ words) Network Bio launches with $50M to read the ‘barcodes’ of disease FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7963831

AI analysis from Brainomix adds to evidence backing Endeavor's IPF therapy

4+ day, 19+ hour ago   (13+ words) FirstWord PHARMA...

firstwordpharma.com
firstwordpharma.com > story > 7969456

Spotlight On: What to watch at World Lung 2026

3+ day, 11+ hour ago   (10+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7937767

KOL Views Preview: What implications does milvexian's failure in Librexia ACS have on the factor XIa class?

1+ week, 4+ day ago   (19+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960147

BrainChild Bio moves CAR-T into pivotal study for paediatric brain cancer

5+ day, 4+ hour ago   (13+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7891566

Novartis joins???97M Kynexis funding round for cognitive disorder drug

3+ week, 4+ day ago   (12+ words) Novartis joins €97M Kynexis funding round for cognitive disorder drug FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7899634

Friday Five??? Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss???and more

3+ week, 2+ day ago   (22+ words) Friday Five – Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss…and more FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7937337

GSK takes dual-target mRNA flu shot to Phase III

1+ week, 4+ day ago   (11+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7916128

Physician Views Preview: One year on, where does Sephience slot into the PKU pecking order?

2+ week, 4+ day ago   (17+ words) FirstWord Pharma...

Web

External web results are waiting for the human check. Complete the press-and-hold control above. Google advertising and AI choices remain separate after verification.